Next GEN recombinant polyclonal antibody discovery platform for the develpment of medical countermeasures
Active Definitive Contract Awarded Last action
- Contract number
- 75A50124C00049
- Awardee
-
Gigagen Inc. UEI HF7MJJDVQQX5
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $29,618,613
Award facts
- Opportunity
-
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Solicitation · BAA23100SOL00004 · Posted Sep 26, 2023
- Contract value 24% obligated
-
- $29,618,612.89 Current, with exercised options
- $125,564,830.25 Potential, with all options
- Completion date 34% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- Q701 Specialized Medical Support
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- San Carlos, CA 94070, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $9,985,386 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $19,633,227 |
About this award
The Office of the Assistant Secretary for Preparedness and Response awarded a definitive contract to Gigagen Inc. for next-generation recombinant polyclonal antibody discovery platform development for medical countermeasures on September 25, 2024. The award exercises option 8 CLIN 0009 for $9.985 million under a cost-plus-fixed-fee structure with a ceiling value of $125.564 million.
Place of performance is San Carlos, California. The originating BARDA solicitation (posted September 26, 2023, with final proposal deadline September 25, 2028) encompasses advanced research and development for medical countermeasures against chemical, biological, radiological, and nuclear threats, pandemic influenza, and emerging infectious diseases across twelve areas of interest. Gigagen's work develops recombinant polyclonal antibody platforms with comprehensive development plans covering regulatory pathways, manufacturing, clinical strategies, and commercialization. The ultimate completion date is December 23, 2030.
Subcontractors include Antibody Solutions (antibody discovery) and Acrobiosystems Inc. (recombinant protein production). The solicitation operates through a three-stage proposal process and anticipates multiple awards of various values and contract types across responsible sources with no incumbent identified. BARDA evaluation emphasizes technical merit and importance to agency programs, with primary consideration of program relevance, scientific and technical capability, offeror experience, cost realism, and past performance. All work must be performed in the United States with compliance to Good Manufacturing Practice, export control regulations, and applicable GLP, GMP, and GCP guidelines.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Antibody Solutions | $934,280 | |
| Acrobiosystems Inc. | $227,628 |
Quick answers
Who was awarded contract 75A50124C00049?
75A50124C00049 was awarded to Gigagen Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 25, 2024.
How much is contract 75A50124C00049 worth?
The government has obligated $29,618,613 on 75A50124C00049. Its potential value, with all options, is $125,564,830.
Was contract 75A50124C00049 competed?
The extent of competition for 75A50124C00049 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award